JMX 2006
Alternative Names: AD20200902; JMX-2006Latest Information Update: 06 Jan 2023
At a glance
- Originator Jemincare
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Breast cancer; Endometriosis; Prostate cancer
Most Recent Events
- 22 Dec 2022 Early research in Breast cancer in China (unspecified route) before December 2022 (Jemincare pipeline, December 2022)
- 22 Dec 2022 Early research in Endometriosis in China (unspecified route) before December 2022 (Jemincare pipeline, December 2022)
- 22 Dec 2022 Early research in Prostate cancer in China (unspecified route) before December 2022 (Jemincare pipeline, December 2022)